ACAM2000® smallpox vaccine
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
15
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Smallpox
Conditions
Smallpox
Trial Timeline
Dec 1, 2008 → Dec 31, 2017
NCT ID
NCT00927719About ACAM2000® smallpox vaccine
ACAM2000® smallpox vaccine is a pre-clinical stage product being developed by Emergent BioSolutions for Smallpox. The current trial status is completed. This product is registered under clinical trial identifier NCT00927719. Target conditions include Smallpox.
Hype Score Breakdown
Clinical
5
Activity
2
Company
2
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00927719 | Pre-clinical | Completed |
Competing Products
20 competing products in Smallpox